Document is current
Any future updates will be listed below
-
Authors
Grattoni, Alessandro https://orcid.org/0000-0001-7888-422X
Korbutt, Gregory
Tomei, Alice A.
García, Andrés J. https://orcid.org/0000-0001-6602-2518
Pepper, Andrew R. https://orcid.org/0000-0002-2227-4446
Stabler, Cherie
Brehm, Michael https://orcid.org/0000-0001-6813-3262
Papas, Klearchos https://orcid.org/0000-0002-4554-0911
Citro, Antonio
Shirwan, Haval https://orcid.org/0000-0002-1657-9470
Millman, Jeffrey R.
Melero-Martin, Juan https://orcid.org/0000-0002-4689-8149
Graham, Melanie
Sefton, Michael
Ma, Minglin
Kenyon, Norma
Veiseh, Omid https://orcid.org/0000-0003-1153-8079
Desai, Tejal A. https://orcid.org/0000-0003-3409-9208
Nostro, M. Cristina https://orcid.org/0000-0003-1166-8252
Marinac, Marjana
Sykes, Megan https://orcid.org/0000-0002-4947-4376
Russ, Holger A.
Odorico, Jon https://orcid.org/0000-0003-1096-464X
Tang, Qizhi https://orcid.org/0000-0001-7313-3574
Ricordi, Camillo
Latres, Esther
Mamrak, Nicholas E.
Giraldo, Jaime
Poznansky, Mark C. https://orcid.org/0000-0003-1344-7103
de Vos, Paul
- License Information
-
More Information
Article History
Accepted: 6 August 2024
First Online: 3 September 2024
Competing interests
: A.G. is a co-founder of Continuity Biosciences LLC, and an inventor of intellectual property licensed by the same company. A.J.G. is an inventor of intellectual property related to technologies for cell therapy in T1DM owned in part by the Georgia Tech Research Corporation, is a co-founder, sits on the Board of Directors, and owns equity interest in iTolerance Inc. H.S. is an inventor on a patent licensed by iTolerance Inc, is a co-founder of the Company, and serves on the scientific advisory board of the Company. M. Ma is a co-founder and equity holder of AvantGuard and Persista Bio. J.O. is co-founder, owns stock equity, and serves on the scientific advisory board of Regenerative Medical Solutions Inc., is a clinical trial investigator for Vertex Pharmaceuticals Inc., and is a member of DSMB for Sernova Corp. J.R.M. is an inventor on related patents and patent applications, was employed at Sana Biotechnology, and has stocks and options in Sana Biotechnology. T.A.D. is a scientific founder of Encellin Inc., a cell therapy device company. K.P. discloses interest in Procyon Technologies LLC. M.C.N. has a sponsored research agreement with Universal Cells Inc., and a patent licensed to Sernova Corp. H.A.R. holds patents in the regenerative medicine space and served as SAB member of Sigilon Therapeutics, Prellis Biologics and consults or consulted for Sigilon Therapeutics, Eli Lilly, Minutia, Guidepoint Global, Axon Advisors and Tolerance Bio. C.R. is scientific adviser to Novo Nordisk, Vertex Pharma and iTolerance, and is a founding scientist of Lipogems International and AION Healthspan. M.C.P. is scientific founder of Vicapsys Life Sciences Inc. All other authors declare no competing interests.
